RNA interference targeting MTHFD2 had been shown to suppress cancer cell malignant features and cause cell death in various cancers, including AML, CRC, HCC, RCC, glioma, breast cancer, lung cancer, ovarian cancer, and melanoma (Supplementary Table 1). This evidence concerns the gene MTHFD2 and central nervous system cancer.